INC Research forms partnership with Debiopharm Group

Wednesday, July 27, 2011 01:25 PM

INC Research, a therapeutically focused CRO, and Debiopharm Group, a Swiss-based global biopharmaceutical group, have formed a strategic partnership.

INC will manage a clinical study linked to an important project in Debiopharm’s pipeline. Both parties have agreed on a framework partnership pertaining to future clinical studies to be conducted by INC for Debiopharm.

“Debiopharm’s reputation and success in establishing partnerships is aligned very closely with our vision of creating strategic relationships that improve the speed, efficiency, and quality of drug development,” said Kelvin Logan, Ph.D., president, INC Research Europe and Asia Pacific.

“This partnership with INC Research will significantly help us in our endeavors to conduct our clinical development programs efficiently, which in turn will enable us to continue to fuel our pipeline with important new medicines,” said Dr. Rolland-Yves Mauvernay, president and founder of Debiopharm.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs